Background: Many different etiologies have been proposed to be responsible for the pathogenesis of chronic rhinosinusitis, including dysbiosis of the sinus microbiome. Attempts have recently been made to identify a pathogenic organism via advanced culture mechanisms. The purpose of this study is to use culture-dependent and culture-independent means of microtyping to determine whether any association exists between the quantity and quality of bacteria identified in patients with recalcitrant chronic rhinosinusitis. Methods: Medical records were retrospectively reviewed for patients with a history of revision sinus surgery and persistent symptoms who underwent endoscopically directed culture and underwent quantitative polymerase chain reaction analysis of the 16S ribosomal RNA of bacteria and fungi from February 1, 2014, to January 1, 2017. A total of 21 patients met the inclusion criteria. Medical records were reviewed to determine the number of bacterial isolates and relative abundance of bacteria and fungi on culture and polymerase chain reaction. Results: Using culture-independent techniques of examining purulent secretions in patients with recalcitrant chronic rhinosinusitis, an average of 3.61 isolates were identified per specimen, compared with culture-dependent methods that revealed 2.10 isolates per specimen (P < .05). The dominant species identified on each culture was rarely the most abundant species identified using polymerase chain reaction techniques. Conclusions: Traditional culture methodologies may fail to identify potential pathogens or the dominant pathogen in patients with recalcitrant chronic rhinosinusitis with acute exacerbations.
Introduction
With significant negative quality-of-life implications, chronic rhinosinusitis (CRS) affects as many as 1 in 10 adults in the United States. 1 Bacteria have traditionally been thought to play a central role in the pathogenesis of this common chronic inflammatory condition, but a newer paradigm suggests that multiple factors play a role. Despite a paucity of high-level evidence supporting their effectiveness, antibiotics and corticosteroids typically are used to treat CRS. However, several studies have recommended using culture-directed antibiotics to treat acute exacerbations of CRS. 2, 3 The CRS management varies significantly. Multiple international consensus statements and practice guidelines fail to offer definitive guidance regarding appropriate medical therapy due to heterogeneity of studies and a paucity of quality. [4] [5] [6] After surgical intervention to reduce the burden of disease and facilitate delivery of topical therapy to the sinuses, acute exacerbations have traditionally been managed with either empiric or culture-directed antimicrobial therapy.
Recently available technology may replace or serve as an adjunct to traditional agar-plate cultures. Several groups have studied the correlation between information obtained from swabs and polymerase chain reaction (PCR) bacteriotyping in healthy volunteers and patients undergoing primary sinus surgery. This association has not been evaluated in patients with CRS that is recalcitrant to medical and surgical therapy. The goal of this study is to compare the accuracy of agar-plate cultures with PCR of the 16S ribosomal RNA (rRNA) in a cohort with recalcitrant CRS.
Materials and Methods
With institutional review board approval, we conducted a retrospective chart review of CRS patients who underwent not only endoscopic sinus surgery but also postoperative sinus cultures and 16S rRNA bacterial typing from February 1, 2014, to January 1, 2017. Patients met the inclusion criteria if they experienced symptoms of CRS (based on the 2015 International Consensus Statement on Allergy and Rhinology definition of CRS) 7 and had undergone endoscopic sinus surgery. Patients with primary immunodeficiencies, cystic fibrosis, and ciliary dyskinesia as well as those treated with antibiotics within 6 weeks of a culture being obtained were excluded.
Cultures and PCR samples of purulent discharge were obtained via endoscopic guidance using the Medtronic sinus aspirator (Medtronic Surgical Technologies, Jacksonville, Florida). Using sterile technique, a swab was used to obtain samples from the sterile collection chamber for culture and PCR. Culture specimens were stored in anaerobic collection tubes while those destined for PCR were placed in specimen tubes for bacteriotyping (Microgen Diagnostics, Lubbock, Texas).
Microbial DNA in each sample was sequenced using the ion torrent personal genome machine (PGM; Thermo Fisher Scientific, Waltham, Massachusetts) to establish what type of bacterial and fungal species were present. Forward and reverse primers were used to detect and amplify the target sequence in each sample. The samples were differentiated from each other when run on the PGM using a tag, a unique identifying sequence attached to the forward primer. The samples then underwent serial amplification. After the sample DNA was amplified and each sample had its own unique sequence tag, the sample DNA was pooled together and purified by removing small fragments using Agencourt Ampure beads (Beckman Coulter, Pasadena, California) and Qiagen Minelute kit (Qiagen, Hilden, Germany). The DNA was added to the emulsion PCR, which attaches one DNA strand to one ion sphere particle. The DNA ion sphere particles were recovered, enriched, and prepared for sequencing. The beads were run on the PGM for quantification. The data for each detected bacterial or fungal species were reported as a relative percentage of total instrument reads. The organism with the highest relative percentage was considered to be the dominant organism. Identification of each organism was performed using GenBank. 8, 9 Traditional cultures were sent to an adjoining clinical microbiology laboratory for aerobic, anaerobic, and fungal cultures. Aerobic culture specimens were plated and streaked on chocolate, colistin nalidixic acid blood, MacConkey, and blood agar. Anaerobic cultures were plated on brucella, colistin nalidixic acid blood, bacteroides bile esculin, laked brucella blood with kanamycin and vancomycin, and chopped meat agars. Fungal cultures were performed by plating specimens onto Sabourand brain heart infusion, brain heart infusion with 5% blood with gentamicin and chloramphenicol, and inhibitory mold agars. Results were reported as no growth, 1þ, 2þ, 3þ, or 4þ. To identify the dominant organism, the highest graded isolate was selected. Multiple organisms with the same grade were considered codominant.
Statistical Analysis
Characteristics of the sample were summarized using descriptive statistics. Means and standard deviations (or medians and ranges for abnormally distributed data sets) were provided for continuous variables. Frequencies and percentages were provided for categorical variables. A Wilcoxon signed-rank test was performed to evaluate for a difference between numbers of cultivates and isolates on culture-independent measures. A P value of <.05 was considered statistically significant. A logistic regression model was performed to test whether identifying a pathogen on culture could be predicted by its relative abundance on PCR.
Results
Of the 21 patients meeting the inclusion criteria, 8 were men and 13 were women. The median age was 60 (range, 24-84) years. Comorbid allergic rhinitis was present in 71.43% of patients. Among the 16 patients who had nasal polyposis, 3 reported a history of nonsteroidal anti-inflammatory drug sensitivity. All patients underwent endoscopic sinus surgery (consisting of maxillary antrostomy, total ethmoidectomy, sphenoidotomy, and frontal sinusotomy), and 14 required at least 1 revision sinus surgery before cultures were obtained. Baseline patient characteristics are summarized in Table 1 .
Median time between culture and last dose of antibiotics was 90 (range, 43-272) days. Traditional sinus cultures obtained a median of 2.00 (range, 0-5) isolates. Advanced technology yielded a statistically significant average of 3.61 (median 3) isolates (P < .05). Asynchrony between the predominant bacteria on culture and 16S rRNA was identified in 71.4% of specimens. Staphylococcus aureus was the single most prevalent bacteria identified on PCR (n ¼ 11) and culture (n ¼ 21). The specific bacteria isolated are summarized in Table 2 . S aureus was the most abundant isolate (n ¼ 4) identified on culture and PCR, and 3 of these specimens were synchronous. S aureus was present in all patients with nasal polyposis. A logistic regression analysis was performed to determine whether increasing relative abundance on PCR increases the odds of identifying the pathogen on PCR. Logistic regression modeling (c ¼ 0.60) showed that for every 1% increase in relative abundance, the chance of being identified on culture increased by 1.3%. This did not reach statistical significance.
Discussion
Characterizing the microbiome of patients with CRS to identify a particular bacterium that may be to blame for mucosal inflammation 10 is not a novel concept. For some time, persistent inflammation and alterations in the gut microbiome have been postulated to predispose individuals to a variety of morbidities. 11 Such characterization has been attempted for other otolaryngic ailments, resulting in evidence of colonization of certain pathogens in adenoidal tissue precipitating recurrent acute otitis media. 12 However, in healthy volunteers, no consistent pattern of microbial habitation predicts CRS; in general, less bacterial diversity exists in patients with CRS. 13, 14 Additionally, children with less nasopharyngeal microbial diversity are more likely to develop acute sinusitis and upper respiratory infections. 15 Unfortunately, current interventions do little to alter a patient's sinonasal microbiome. Despite endoscopic sinus surgery and aggressive antibiotic treatments, a patient's microbiome returns to its preoperative state within 6 weeks of surgery. 16 Agar-plate cultures have been used to study purulent drainage in patients with acute exacerbations of CRS, but this may not be truly representative of these patients' microbiome. Recent investigations have estimated that as much as 60% of the human-associated microbiome is uncultivable. 17 To better characterize the microbiome of the sinuses and nasal cavities, new molecular techniques have been developed using 16S rRNA gene cloning and terminal restriction fragment length polymorphism analysis. Patients with a more diverse microbiome are more likely to see improved outcomes. 18 The middle meatus, which is readily accessible in the clinic, is fairly representative of the microbiome of the entire sinonasal cavity, as has recently been shown. 19 In acute exacerbations of sinusitis in patients with CRS, our current practice is to obtain endoscopically guided cultures in acute exacerbations of sinusitis and direct antibiotic coverage toward the predominant pathogen. A variety of studies have aimed to elucidate the efficacy of culture-directed antimicrobial therapy in treating CRS and its acute exacerbations. Empiric antibiotics are often started for acute exacerbations, and it has been shown that information that is obtained from cultures led to a change in therapy in a significant portion of cases. 20, 21 This treatment approach has resolved purulent drainage, significantly improving quality of life. 2 With new culture-independent techniques available to characterize these patients' microbiome, a search has begun for elusive bacteria that may be to blame for persistent mucosal inflammation. Several studies have attempted to correlate this new technique with traditional cultures. Culture-independent methods have been shown to result in a significant change in the number of isolates identified in patients with CRS undergoing primary endoscopic sinus surgery as well as showing a quantitative increase in S aureus. 13 Using quantitative data, another group showed little correlation between the most prevalent cultivar and most abundant bacteria shown by 16S rRNA quantification. 16 This finding is consistent with our study of a recalcitrant population, which showed a statistically significant increase in the number of pathogens identified with PCR and an asynchrony in the dominant organism. The lack of correlation may be related to the inadequate bacterial growth environment of plates, the lack of time allowed for growth before reporting, or heightened sensitivity to low-abundance bacteria. Additionally, bacteria associated with a biofilm have lower metabolic activity and therefore slower growth activity in culture media.
This study is limited due to its small sample size and retrospective nature. Significant selection bias may exist because patients were selected to undergo molecular testing based on clinical judgment of severe, refractory CRS. Furthermore, the cohort is heterogeneous with a trend toward a CRS with nasal polyposis phenotype. Unfortunately, the retrospective design of this study prevented the authors from evaluating outcomes based on directing therapy from the information gained from PCR compared with culture; evaluating this should be the aim of future studies. To the authors' knowledge, this is the only study that has examined the association between bacteria identified from purulent sinonasal secretions in a patient population with CRS recalcitrant to medical and surgical management.
Conclusion
Endoscopically guided cultures of the sinus may not provide enough information to determine appropriate treatment for patients with recalcitrant CRS. Further studies are required to determine the efficacy of DNA-directed antimicrobial treatment in this population.
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